Tatsuro Watanabe
Plus aucun poste en cours
Provenance du réseau au premier degré de Tatsuro Watanabe
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tatsuro Watanabe via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Chairman Director/Board Member President Director of Finance/CFO | |
EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NICHIBAN CO., LTD. | Pulp & Paper | Director/Board Member | |
OTSUKA PAKISTAN LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Mizuho Bank Ltd.
Mizuho Bank Ltd. Regional BanksFinance Mizuho Bank Ltd. engages in financial service business. It offers services such as buying and selling of securities, lending, deposits, securities investment, domestic exchange settlement, foreign exchanges transaction, and corporate bond trustee and register services. It also deals in buying and selling of gold, public bond underwriting, sale of public bonds, lottery, trust agent, and consulting services. The company was founded on May 7, 1923 and is headquartered in Tokyo, Japan. | Regional Banks | Corporate Officer/Principal | |
Otsuka Pharmaceutical Factory, Inc.
Otsuka Pharmaceutical Factory, Inc. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IBJ Associates Ltd.
IBJ Associates Ltd. MiscellaneousMiscellaneous Part of Lloyds of London Press Ltd., IBJ Associates Ltd. is a publisher of the magazine, International Bulk Journal. The company is based in London, UK. IBJ Associates was acquired by Lloyds of London Press Ltd. on August 01, 1995. | Miscellaneous | Corporate Officer/Principal | |
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Chairman President | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
University of Tokyo | College/University | Undergraduate Degree | |
Otsuka Estate YK
Otsuka Estate YK Financial ConglomeratesFinance Otsuka Estate YK operates as an investment holding Japanese company. The company is based in Osaka, Japan. | Financial Conglomerates | President | |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chief Executive Officer | |
MICROPORT SCIENTIFIC CORPORATION | Medical Specialties | Director/Board Member | |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Equipment/Instruments | Director/Board Member | |
Otsuka Chemical Co., Ltd.
Otsuka Chemical Co., Ltd. Chemicals: SpecialtyProcess Industries Otsuka Chemical Co., Ltd. engages in the production of chemicals and diet supplements. It provides inorganic salts, bromides, hydrazine, foaming agent, polymerization initiator, preparation articles, rust-preventive agent, fire retarding material, intermediates, and electro-organic synthesis products. The company was founded on August 29, 1950 and is headquartered in Tokyo, Japan. | Chemicals: Specialty | Director/Board Member | |
MEGMILK SNOW BRAND CO.,LTD. | Food: Meat/Fish/Dairy | President | |
International University of Health & Welfare | College/University | Corporate Officer/Principal | |
Otsuka Foods Co. Ltd.
Otsuka Foods Co. Ltd. Food: Major DiversifiedConsumer Non-Durables Part of Otsuka Holdings Co., Ltd., Otsuka Foods Co. Ltd. is a Japanese company that specializes in processed foods, frozen foods, and beverages. The company is based in Osaka, Japan. The company's website features information about their products, corporate information, safety and security initiatives, campaign information, and commercials. One of their products is milk tea with a deep and rich taste, which aims to bring the taste of the restaurant to the comfort of one's home. | Food: Major Diversified | Chairman | |
Otsuka Asset KK | President | ||
Otsuka Medical Devices Co., Ltd.
Otsuka Medical Devices Co., Ltd. Medical SpecialtiesHealth Technology Otsuka Medical Devices Co., Ltd. engages in medical equipment business focusing on therapeutic devices. Its devices include ultrasound-based renal denervation, drug device combinations, and novel solutions for drug-refractory patients and intractable diseases. The company was founded on February 15, 2011 and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
MicroPort Medical Ltd. | Director/Board Member | ||
Leader City Ltd. | Director/Board Member | ||
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member | |
MicroPort Lifesciences (Shanghai) Co. Ltd. | Director/Board Member | ||
MicroPort Lifesciences (Beijing) Co. Ltd. | Director/Board Member | ||
MicroPort Orthopedics Shanghai Co. Ltd. | Director/Board Member | ||
MicroPort NeuroTech (Shanghai) Co., Ltd. | Director/Board Member | ||
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. | Medical Specialties | Director/Board Member | |
D-Pulse Medical (Beijing) Co. Ltd. | Director/Board Member | ||
Dongguan Kewei Medical Co. Ltd. | Director/Board Member | ||
Erivan K. Haub School of Business | College/University | Masters Business Admin | |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chairman | |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Pharmaceuticals: Major | Chairman | |
V ClinBio LLC
V ClinBio LLC BiotechnologyHealth Technology V ClinBio LLC operates as an biopharmaceutical company driving the development of novel drug products for treatment of immune and other related diseases. It develops New Molecular Entities using repurposing, incremental innovation and prodrug technology. The company was founded by Subbu Apparsundaram in 2013 and is headquartered in Newark, NJ. | Biotechnology | Chief Executive Officer | |
Japan Public Health Association | Chairman | ||
PSYBIO THERAPEUTICS CORP. | Biotechnology | Director/Board Member | |
ALLARITY THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hyalo Technologies LLC | Director/Board Member |
Statistiques
Internationale
Japon | 19 |
Etats-Unis | 12 |
Chine | 11 |
Canada | 3 |
Pakistan | 2 |
Sectorielle
Health Technology | 20 |
Consumer Services | 5 |
Consumer Non-Durables | 4 |
Finance | 4 |
Process Industries | 3 |
Opérationnelle
Director/Board Member | 44 |
President | 10 |
Chairman | 8 |
Independent Dir/Board Member | 6 |
Corporate Officer/Principal | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Tatsuro Watanabe
- Connexions Sociétés